Page last updated: 2024-08-23

bromocriptine and Cancer, Second Primary

bromocriptine has been researched along with Cancer, Second Primary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liberante, FG; McMullin, MF; Mills, KI; Pouryahya, T; Zhang, SD1
Alfonso Collado, JI; Domínguez Ugidos, LJ; Martínez Subías, J; Sancho Serrano, E; Urpegui García, A; Vallés Varela, H1

Reviews

1 review(s) available for bromocriptine and Cancer, Second Primary

ArticleYear
[Invasive giant prolactinoma].
    Acta otorrinolaringologica espanola, 1998, Volume: 49, Issue:2

    Topics: Adult; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasms, Second Primary; Pituitary Neoplasms; Prolactinoma; Skull Base Neoplasms

1998

Other Studies

1 other study(ies) available for bromocriptine and Cancer, Second Primary

ArticleYear
Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia.
    Oncotarget, 2016, Feb-09, Volume: 7, Issue:6

    Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Bromocriptine; Case-Control Studies; Cell Proliferation; Dopamine Agonists; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Tumor Cells, Cultured

2016